From: Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
Characteristic | Total Sample (N = 130) | Edinburgh (N = 53) | London (N = 77) | p value1 |
---|---|---|---|---|
Age (mean, SD) | 55.7 (10.3) | 56.2 (8.8) | 55.4 (11.3) | 0.69 |
Gender (n, %) | Â | Â | Â | Â |
Male | 84 (64.6%) | 33 (62.3%) | 51 (66.2%) | 0.71 |
Female | 46 (35.4%) | 20 (37.7%) | 26 (33.8%) | Â |
Ethnicity (n, %) | Â | Â | Â | Â |
White | 105 (80.8%) | 53 (100.0%) | 52 (67.5%) | <0.0001 |
Black | 8 (6.2%) | 0 (0.0%) | 8 (10.4%) | Â |
Indian | 8 (6.2%) | 0 (0.0%) | 8 (10.4%) | Â |
Other | 9 (6.9%) | 0 (0.0%) | 9 (11.7%) | Â |
Marital Status (n, %) | Â | Â | Â | Â |
Married | 79 (60.8%) | 37 (69.8%) | 42 (54.5%) | 0.10 |
Not married | 51 (39.2%) | 16 (30.2%) | 35 (45.5%) | Â |
Employment Status (n, %) | Â | Â | Â | Â |
Full-time work | 46 (35.4%) | 19 (35.8%) | 27 (35.1%) | 0.91 |
Retired | 47 (36.2%) | 20 (37.7%) | 27 (35.1%) | Â |
Other | 37 (28.5%) | 14 (26.4%) | 23 (29.9%) | Â |
Education Level (n, %) | Â | Â | Â | Â |
Did not complete college degree | 86 (66.2%) | 40 (75.5%) | 46 (59.7%) | 0.089 |
Completed college degree or higher | 44 (33.8%) | 13 (24.5%) | 31 (40.3%) | Â |
Body Mass Index 2 | 31.5 (5.4) | 32.3 (5.6) | 31.0 (5.3) | 0.19 |
Age when Diagnosed with Diabetes (mean, SD) | 49.1 (11.2) | 49.1 (11.2) | 49.2 (11.3) | 0.96 |
Current Treatment (n, %) | Â | Â | Â | Â |
Diet and/or exercise alone | 14 (10.8%) | 6 (11.3%) | 8 (10.4%) | 0.34 |
Oral meds alone (no injectable) | 85 (65.4%) | 31 (58.5%) | 54 (70.1%) | Â |
Injectable medication with or without other treatment | 31 (23.8%) | 16 (30.2%) | 15 (19.5%) | Â |
Other Health Conditions (n, %) | Â | Â | Â | Â |
Hypertension (n, %) | 48 (36.9%) | 17 (32.1%) | 31 (40.3%) | 0.36 |
Diabetic retinopathy (n, %) | 7 (5.4%) | 3 (5.7%) | 4 (5.2%) | 1.00 |
Depression or other mental health condition (n, %) | 17 (13.1%) | 7 (13.2%) | 10 (13.0%) | 1.00 |
Other Health Condition(s) (n, %) | 56 (43.1%) | 25 (47.2%) | 31 (40.3%) | 0.47 |
None (n, %) | 45 (34.6%) | 16 (30.2%) | 29 (37.7%) | 0.45 |